Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.84%170.810.0%$1433.85m
AMGNAmgen, Inc. 0.23%255.711.3%$690.21m
NVAXNovavax, Inc. 12.50%227.3580.0%$655.57m
SNSSSunesis Pharmaceuticals, Inc. -0.37%8.000.7%$559.23m
ILMNIllumina, Inc. -0.74%399.003.5%$519.65m
GILDGilead Sciences, Inc. 1.67%66.871.0%$470.50m
REGNRegeneron Pharmaceuticals, Inc. 1.61%502.602.7%$458.74m
VRTXVertex Pharmaceuticals, Inc. -0.77%219.391.9%$388.60m
ALXNAlexion Pharmaceuticals, Inc. 3.90%163.682.0%$348.10m
BNTXBioNTech SE 7.69%151.540.0%$313.57m
BIIBBiogen, Inc. -0.05%270.311.7%$263.29m
EXASEXACT Sciences Corp. -0.37%130.0418.4%$186.19m
NBIXNeurocrine Biosciences, Inc. 1.66%96.584.9%$179.73m
CRSPCRISPR Therapeutics AG -4.27%118.560.6%$166.57m
SGENSeagen Inc. -2.77%145.505.8%$146.84m

Company Profile

Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.